California's Stem Cell Agency Hits 45 Clinical Trials
Directors of the $3 billion California stem cell agency yesterday added another clinical trial to its portfolio, bringing to 45 the number of its forays into the late stage research that is the most likely to produce a therapy sooner rather than later.
The decision on the $5.7 million award carries more weight in terms of the viability of the agency tha…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.